WCN25-778 AFFINITY study: 1-year results of atrasentan in IgA nephropathy (IgAN)
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924023830 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849690936147181568 |
|---|---|
| author | Jonathan Barratt Sung Gyun Kim Lesley A. Inker David K. Packham Dwarakanathan Ranganathan Michelle N. Rheault Mark Vishnepolsky Yasmin Brahmbhatt Yi Wang Valeria Beckett Seung Hyeok Han |
| author_facet | Jonathan Barratt Sung Gyun Kim Lesley A. Inker David K. Packham Dwarakanathan Ranganathan Michelle N. Rheault Mark Vishnepolsky Yasmin Brahmbhatt Yi Wang Valeria Beckett Seung Hyeok Han |
| author_sort | Jonathan Barratt |
| collection | DOAJ |
| format | Article |
| id | doaj-art-cfff215cd34f4ffbb6bf854a9a773072 |
| institution | DOAJ |
| issn | 2468-0249 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Kidney International Reports |
| spelling | doaj-art-cfff215cd34f4ffbb6bf854a9a7730722025-08-20T03:21:11ZengElsevierKidney International Reports2468-02492025-02-01102S18310.1016/j.ekir.2024.11.361WCN25-778 AFFINITY study: 1-year results of atrasentan in IgA nephropathy (IgAN)Jonathan Barratt0Sung Gyun Kim1Lesley A. Inker2David K. Packham3Dwarakanathan Ranganathan4Michelle N. Rheault5Mark Vishnepolsky6Yasmin Brahmbhatt7Yi Wang8Valeria Beckett9Seung Hyeok Han10Department of Cardiovascular Sciences, University of Leicester, Cardiovascular Sciences, Leicester, United KingdomDept. of Internal Medicine, Div. of Nephrology, Hallym University Sacred Heart Hospital, Anyang, Gyeonggi-do, Korea (Republic of)School of Medicine, Tufts Medical Center, Boston, MA, United StatesDepartment of Medicine, Melbourne Renal Research Group, Reservoir, Victoria, AustraliaDepartment of Renal Medicine, Royal Brisbane and Women's Hospital, Herston, Queensland, AustraliaDivision of Pediatric Nephrology, University of Minnesota, Minneapolis, MN, United StatesClinical Nephrology, Kidney Specialists of Southern Nevada, Las Vegas, NV, United StatesGlobal Drug Development, Novartis Pharmaceuticals Corporation, East Hanover, NJ, United StatesCell & Gene Therapy Full Dev Biostats, Novartis Pharmaceuticals Corporation, East Hanover, NJ, United StatesA Novartis Company, Chinook Therapeutics Inc, Seattle, WA, United StatesYonsei University Health System, Severance Hospital, Seoul, Korea (Republic of)http://www.sciencedirect.com/science/article/pii/S2468024924023830 |
| spellingShingle | Jonathan Barratt Sung Gyun Kim Lesley A. Inker David K. Packham Dwarakanathan Ranganathan Michelle N. Rheault Mark Vishnepolsky Yasmin Brahmbhatt Yi Wang Valeria Beckett Seung Hyeok Han WCN25-778 AFFINITY study: 1-year results of atrasentan in IgA nephropathy (IgAN) Kidney International Reports |
| title | WCN25-778 AFFINITY study: 1-year results of atrasentan in IgA nephropathy (IgAN) |
| title_full | WCN25-778 AFFINITY study: 1-year results of atrasentan in IgA nephropathy (IgAN) |
| title_fullStr | WCN25-778 AFFINITY study: 1-year results of atrasentan in IgA nephropathy (IgAN) |
| title_full_unstemmed | WCN25-778 AFFINITY study: 1-year results of atrasentan in IgA nephropathy (IgAN) |
| title_short | WCN25-778 AFFINITY study: 1-year results of atrasentan in IgA nephropathy (IgAN) |
| title_sort | wcn25 778 affinity study 1 year results of atrasentan in iga nephropathy igan |
| url | http://www.sciencedirect.com/science/article/pii/S2468024924023830 |
| work_keys_str_mv | AT jonathanbarratt wcn25778affinitystudy1yearresultsofatrasentaniniganephropathyigan AT sunggyunkim wcn25778affinitystudy1yearresultsofatrasentaniniganephropathyigan AT lesleyainker wcn25778affinitystudy1yearresultsofatrasentaniniganephropathyigan AT davidkpackham wcn25778affinitystudy1yearresultsofatrasentaniniganephropathyigan AT dwarakanathanranganathan wcn25778affinitystudy1yearresultsofatrasentaniniganephropathyigan AT michellenrheault wcn25778affinitystudy1yearresultsofatrasentaniniganephropathyigan AT markvishnepolsky wcn25778affinitystudy1yearresultsofatrasentaniniganephropathyigan AT yasminbrahmbhatt wcn25778affinitystudy1yearresultsofatrasentaniniganephropathyigan AT yiwang wcn25778affinitystudy1yearresultsofatrasentaniniganephropathyigan AT valeriabeckett wcn25778affinitystudy1yearresultsofatrasentaniniganephropathyigan AT seunghyeokhan wcn25778affinitystudy1yearresultsofatrasentaniniganephropathyigan |